Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
This report studies the Refractive Surgery Devices market, Refractive Surgery Devices are the devices used for refractive surgery.
Refractive eye surgery is any eye surgery used to improve the refractive state of the eye and decrease or eliminate dependency on glasses or contact lenses. This can include various methods of surgical remodeling of the cornea or cataract surgery. The most common methods today use excimer lasers to reshape the curvature of the cornea. Successful refractive eye surgery can reduce or cure common vision disorders such as myopia, hyperopia and astigmatism, as well as degenerative disorders like keratoconus.
Scope of the Report:
Refractive eye surgery is any eye surgery used to improve the refractive state of the eye and decrease or eliminate dependency on glasses or contact lenses. This can include various methods of surgical remodeling of the cornea or cataract surgery. The most common methods today use excimer lasers to reshape the curvature of the cornea.
In the last several years, global market of Refractive Surgery Devices developed stably, with an average growth rate of 5.8%. In 2017, global revenue of Refractive Surgery Devices is nearly 490 M USD; the actual production is about 3150 Units.
The classification of Refractive Surgery Devices includes Excimer Laser Systems, Femtosecond Laser System and other, and the proportion of Excimer Laser Systems in 2017 is about 62%, and the proportion is decreasing trend from 2012 to 2017.
The worldwide market for Refractive Surgery Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new WMR study.
This report focuses on the Refractive Surgery Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bausch and Lomb (Valeant)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Excimer Laser Systems
Femtosecond Laser System
Market Segment by Applications, can be divided into
Ambulatory Surgical Centers
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Refractive Surgery Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Refractive Surgery Devices, with price, sales, revenue and global market share of Refractive Surgery Devices in 2017 and 2018.
Chapter 3, the Refractive Surgery Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Refractive Surgery Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Refractive Surgery Devices market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Refractive Surgery Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.